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Abstract
Context. Fertility control appears as a publicly acceptable alternative to lethal methods for limiting population growth in
wildlife. Recently developed single-dose immunocontraceptive vaccines have induced infertility in several mammals.
However, the potential side-effects and the long-term effectiveness of these contraceptives have been poorly investigated.
Aims. We tested the long-term effectiveness and potential side-effects of the single-dose gonadotrophin-releasing
hormone (GnRH) vaccine GonaCon on captive female wild boar.
Methods. We carried out two sequential trials: Trial 1 (n = 6 GonaCon-treated and 6 control wild boar) and Trial 2 which
started two years later and replicated Trial 1. We assessed the effectiveness of GonaCon to cause infertility by measuring
GnRH antibody titres, by monitoring the oestrous cycle through the concentration of faecal progesterone and by recording the
sows’ reproductive output in the 4–6 years following treatment. We evaluated the potential side-effects by monitoring
behaviour, bodyweight and haematological and biochemical variables.
Key results. GnRH-antibody titres decreased with time but were still detectable in all females six years after vaccination
with a single dose of GonaCon. In Trial 1 none of the treated females gave birth in the six years after vaccination. In Trial
2, progesterone indicated that two of the six treated females were cycling. One of the cycling treated females gave birth
one year after vaccination; the other ﬁve, including the second cycling sow, did not reproduce in the four years following
vaccination. We found no differences in bodyweight, haematology, biochemistry and behaviour and no obvious sign of
injection site reaction.
Conclusions. GonaCon can suppress reproduction in wild boar with no long-term effects on behaviour and physiology.
Therefore, GonaCon can be regarded as an effective and safe contraceptive for this species.
Implications. The lack of evidence of adverse effects and the longevity of effect of GonaCon suggest that this
contraceptive could be now tested in ﬁeld trials and in contexts where culling of overabundant populations of wild boar is
unfeasible, illegal or unacceptable. These instances include urban areas, parks, and management of diseases where culling
might cause social perturbation and result in increased disease transmission rates.
Received 29 November 2011, accepted 13 April 2012, published online 28 May 2012

Introduction
Current trends of landscape development and human population
growth suggest that human–wildlife conﬂicts, often associated
with overabundant or expanding animal populations, are likely
to increase in the near future (Messmer 2009; White and Ward
2010). Traditional methods employed to mitigate these conﬂicts,
such as culling or toxicants, can be inefﬁcient in the long term,
environmentally hazardous and may compromise animal welfare
(Waddell et al. 2001; Delsink et al. 2006; Massei et al. 2010a).
At the same time, growing public antipathy towards lethal
control places increasing constraints on management options,
particularly for species that have a high public proﬁle (Barr
et al. 2002; Deigert et al. 2003; Thornton and Quinn 2009).
Translocation of problem animals is often advocated as a

humane alternative to culling. However, translocations are
expensive, may have negative effects on animal welfare, can
be responsible for introduction of pathogens and may not
provide long-term solutions (Massei et al. 2010a). Conversely,
fertility control has the potential to offer a long-term, effective
and humane means of reducing the size and growth of
overabundant wildlife populations (Fagerstone et al. 2002;
Rutberg and Naugle 2008). Increasing numbers of theoretical
and empirical models on the effects of fertility control on
population dynamics of wildlife suggest that this approach
could be as effective as or even more effective than culling to
reduce population size (Hobbs et al. 2000; Merrill et al. 2003;
Bradford and Hobbs 2008). Theoretical models also predict
that fertility control could play a signiﬁcant role in disease
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management when used alongside vaccination: for instance,
immunocontraception added to rabies vaccination could
improve rabies control campaigns by reducing the proportion
of the population that must be treated, or by reducing the
duration of the vaccination campaign (Smith and Cheeseman
2002; Ramsey 2007; Carroll et al. 2010; Massei in press).
A contraceptive suitable for ﬁeld applications in wildlife
management (Fagerstone et al. 2010; Gionfriddo et al. 2011)
should: (1) render a high proportion of animals infertile for
several years after administration of a single dose, (2) have nil
or minimal negative side-effects, (3) target preferentially
females but ideally be also effective on males, (4) be relatively
inexpensive, and (5) be available as an oral formulation.
Recently developed, single-dose immunocontraceptives meet
most of these criteria, although these compounds are currently
available only as injectable formulations.
Immunocontraceptive vaccines act by inducing antibodies
against proteins or hormones essential for reproduction
(Delves 2002). The gonadotropin-releasing hormone (GnRH)
peptide used in GnRH immunocontraceptives is secreted by
the hypothalamus of the brain and stimulates the secretion of
luteinising and follicle-stimulating hormones by the anterior
pituitary gland (Miller et al. 2008a). These hormones, in turn,
activate hormone and gamete production by the ovary and
by the testis. GnRH-based immunocontraceptives cause the
production of GnRH antibodies, thus preventing the
production of sex hormones and ultimately inhibiting
ovulation and spermatogenesis. Several GnRH-based
immunocontraceptive vaccines have been developed and
tested on many species of mammals, including humans. Most
of these vaccines, designed for livestock and companion
animals, are administered in multiple doses (reviewed in
McLaughlin and Aitken 2010) and, as such, they are
unsuitable for wildlife applications. However, single-dose
GnRH-based injectable vaccines appear more promising for
wildlife management (Fagerstone et al. 2002; Kirkpatrick
et al. 2011). Among these, the single-dose injectable GnRH
vaccine GonaCon was found to cause infertility for
1–5 years in many species of mammals (e.g. Miller et al.
2000, 2008b; Killian et al. 2008a; Massei et al. 2008; Gray
et al. 2010).
Few studies have investigated the duration of induced
infertility in conjunction with the potential long-term sideeffects of GonaCon on physiology and behaviour. A study
carried out by Massei et al. (2008) on captive female wild
boar established that GonaCon had rendered all treated sows
(n = 6) infertile for at least one year and that in the four months
following vaccination GonaCon had had no effect on the
behaviour and on the haematological and biochemical
variables of the sows (n = 12 treated and 12 controls), although
treated females had greater bodyweight than controls. However,
if fertility control is going to be used to manage populations
of long-lived animals, such as wild boar and other ungulates,
the potential side-effects and long-term effectiveness of a
contraceptive must be assessed. Evaluating the long-term
effectiveness of a contraceptive is needed to predict the effects
of fertility control, in terms of proportion of infertile animals
and longevity of effect, on population size. For territorial or
hierarchically structured species, contraception-induced changes
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in social behaviour, such as decreased aggressiveness, could
lead to disruption of social hierarchies and spacing behaviour
and, in turn, affect the impact of fertility control on a population
(Saunders et al. 2002; Crawford et al. 2011). The potential
impact of a contraceptive on social behaviour should thus be
evaluated before fertility control is used to manage wildlife
populations.
This study expanded the work initiated by Massei et al.
(2008) and aimed at evaluating the long-term effectiveness
and potential side-effects of GonaCon on physiology and
behaviour of captive female wild boar. Wild boar was used as
a model species because of its worldwide distribution, as native
or introduced species, and its impact on human interests. The
latter include damage to crops and livestock, spread of diseases,
vehicle collisions and reduction in plant and animal abundance
and richness (e.g. Hone 2002; Engeman et al. 2004; Massei and
Genov 2004; Conover 2007). Although the species can be
controlled through hunting (Massei et al. 2011), it is essential
to evaluate different options to manage overabundant
populations, particularly in urban and/or protected areas where
culling is unfeasible or undesirable.
Materials and methods
The study was conducted in two trials, Trial 1 and Trial 2,
between 2004 and 2010.
In 2004, 2-year-old wild boar females (n = 12) of proven
fertility were obtained from a local farm and housed as a
single group in three interconnected outdoor paddocks (each
77  24 m). Animals were fed on commercial pig diet, offered
ad libitum water and equipped with coloured ear-tags for
individual identiﬁcation. Six females were unexpectedly found
to be pregnant and births occurred in early July. All the piglets
were removed by a veterinarian within 3 days of birth. On 17
August 2004 females were randomly assigned to Treatment
group (n = 6) and injected intramuscularly in the rump with
1000 mg of GonaCon, or to Control group (n = 6) and injected
with the adjuvant only. Each group comprised 3 previously
pregnant and 3 non-pregnant females. Trial 2 was designed to
replicate Trial 1 and to monitor the effects of GonaCon on
the reproductive cycle of wild boar. On 26 April 2006 new
female wild boar were randomly assigned to the Treatment
(n = 6) or Control group (n = 6), as in Trial 1. Controls in Trial
2 were injected with a saline solution only as Trial 1 had shown
that the adjuvant had no obvious adverse injection site reaction
(Massei et al. 2008). In both trials, the vaccine contained the
mollusc protein Keyhole limpet hemocyanin as a carrier.
Two males were introduced with the sows of Trial 1 in
November 2004. Once births had occurred, following the
introduction of the males into the paddocks, all control
females and the piglets born in Trial 1 were removed from the
experiment in August 2005. Therefore, from April 2006, the
following groups of wild boar were studied: Treated in Trial 1,
Treated in Trial 2 and Control in Trial 2. All treated females
from Trial 1 were housed continuously with a male wild boar from
May 2006 till December 2010.
In June 2007 one male was introduced for three months with
the sows of Trial 2. After births had occurred, all piglets were
removed. In January 2010 the male boar normally housed with
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the females in Trial 1 was introduced again for three months
with the sows of Trial 2.
Effectiveness of GonaCon to induce long-term infertility
The effectiveness of the vaccine to maintain infertility was
determined by collecting the following data: (1) immune
response to the vaccine, assessed by measuring serum
antibodies to the GnRH, (2) concentration of faecal
progesterone used as an indicator of cycling, and (3)
reproductive output.
Blood samples were collected from all sows under anaesthesia
at vaccination, 6 and 12 weeks after vaccination and thereafter
every 6–9 months. Animals were anaesthetised by a mixture of
Zoletil® (tiletamine–zolazepam), Zalopine® (medetomidine
hydrochloride) and Torbugesic® (butorphanol tartrate)
administered by dart gun. The enzyme-linked immunosorbent
assay (ELISA) was used to measure anti-GnRH antibody titres.
Fifty microlitres of wild boar serum were used for each assay. A
96-well plate was prepared by adding 100 ng of Bovine Serum
Albumin (BSA)-GnRH antigen to each well and then blocking
with SeaBlock from Pierce Chemical. Antibodies to GnRH in the
wild boar serum were detected by placing a BSA-GnRH on the
ELISA plate. Wild boar serum was serially diluted from 1 : 1000
to 1 : 128 000 in phosphate-buffered saline containing SeaBlock.
Antibodies in the wild boar serum to GnRH on the plate were
detected with the following linkages: rabbit anti–wild boar
IgG, bound to the wild boar IgG, and horseradish peroxidase
(HRP)-goat anti–rabbit bound to the rabbit IgG. Chromogen
tetramethylbenzidine was used to develop the colour, and 2 M
H2SO4 was used to stop the reaction. The colour intensity of
the sample was read at 450 nm with a Dynatech MR 5000 ELISA
plate and expressed as an absorbance value. Anti-GnRH antibody
titres were calculated by comparing blood samples between preand postvaccination, and expressed as the highest dilution
(i.e. 1 : 16 000, 1 : 32 000 or 1 : 64 000) in which the
postvaccination sample had a higher absorbance value than
that of the prevaccination sample.
Samples with titres higher than 1 : 128 000 were rerun with
serial dilution from 1 : 4000 to 1 : 512 000.
During the wild boar breeding season, between 23 November
and 17 December 2009, faecal samples were collected by staff
who followed individual animals until the faecal sample was
produced. Samples were collected twice a week from all
females of Trial 2 and then processed as described in Massei
et al. (2008). A fully validated ELISA was used to measure the
concentration of progesterone as described in Massei et al.
(2008).
Reproductive output was assessed by the number of females
giving birth. Differences in the proportions of treated and
control animals pregnant at the end of the study, in 2010, were
analysed by Fisher’s Exact Test. Bodyweight was recorded
every 6–9 months in parallel with blood collection for
antibody titres.
Effects of GonaCon on behaviour and physiology
To determine whether vaccination with GonaCon affected
the social rank of wild boar, behavioural data on agonistic
interactions with trial mates were collected as described in
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Massei et al. (2008) and compared between trials and before
and after vaccination. In Trial 1 prevaccination was in
July–August 2004 and postvaccination in August 2004–March
2005; in Trial 2 prevaccination was in November 2005–April
2006 and postvaccination was in April 2006–April 2007. In
brief, the behaviour of each animal was observed in 3-h
sessions carried out once or twice every fortnight and the
identity of the animal initiating or receiving an agonistic
interaction was noted. The Barrette and Vandal (1986) index
on agonistic interactions (AI) was derived for each animal as
follows:
AI index ¼ ðno: of AI initiated þ 1Þ=ðno: of AI received þ 1Þ
A REML analysis was carried out on the AI indices to test for
the effect of trial, treatment (treated versus control) and
vaccination period (before and after vaccination).
Differences in bodyweight between groups were analysed
by an Analysis of Covariance (ANCOVA). Data were log10transformed and the initial weight, recorded at vaccination, was
used as covariate.
A general blood chemistry panel was performed on blood
samples by Carmichael Torrance Diagnostic Services Ltd
(Leeds, UK). For each sample, the following biochemical
parameters were collected: a-, b- and gamma-globulins,
ionised calcium, albumin, urea, creatinine, alkaline
phosphatase, aspartate aminotransferase, gamma-glutamyl
transferase, sodium, potassium, calcium and bile acids. The
following haematological parameters were also collected:
haemoglobin, packed cell volume, red blood cell count, white
blood cell count, mean corpuscular volume, mean corpuscular
haemoglobin concentration, neutrophils and lymphocytes. Data
from the last collection date were used to compare biochemical
and haematological values of treated and control females. In
October 2009, the following animals were sampled: four treated
sows in Trial 1, 62 months after vaccination, and 12 sows in Trial 2
(n = 6 treated and 6 controls) 42 months after vaccination.
Differences in haematological and biochemical values between
treated and control animals were analysed with a Multivariate
Analysis of Variance (MANOVA). Data analyses were carried
out in GENSTAT 13 (Payne 2003).
The study was carried out under a UK Home Ofﬁce licence, in
accordance with the Animals (Scientiﬁc Procedures) Act 1986
and was approved by the Food and Environment Research
Agency’s Ethical Review Process.

Results
Effectiveness of GonaCon to induce long-term infertility
Two treated animals in Trial 1 died under anaesthesia, one in
July 2007 and one in October 2009, for causes believed to be
unrelated to the vaccine. The analysis of GnRH antibody titres
showed a long-term, sustained immune response in both groups
of treated wild boar (Fig. 1). Notably, after an initial drop in
the 12–24 months following vaccination, antibody titres stayed
relatively but consistently low (1 : 64 000) in subsequent years
and were associated with infertility in 11 out of 12 treated
animals (see below). Antibodies were not measured in control
animals as these sows were not expected to have anti-GnRH titres.

Long-term wild boar immunocontraception
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Fig. 1. Mean anti-GnRH antibody titres (s.d.) of female wild boar treated
with GonaCon in Trial 1 (n = 6) and Trial 2 (n = 6).

The results on progesterone levels indicated that in all 6
control and in 2 treated females in Trial 2 progesterone
peaked from 100–500 ng g–1 during the follicular phase
preceding ovulation to 8000–15 000 ng g–1 during the luteal
phase following ovulation (Table 1). The GnRH antibody
titres of the two treated animals that appeared to cycle (PuPu
and RG), measured 1 : 32 000 whereas the titres of all the
other wild boar were 1 : 64 000. In all the other four treated
females progesterone levels varied between 67 and
1761 ng g–1.
In October 2007 all control females in Trial 2 and one
treated female (PuPu) gave birth. In May–June 2010, ﬁve
control females in Trial 2 and the same treated female (PuPu)
gave birth to 5–7 piglets per litter. The control that did not
give birth (YPu) was cycling like the other controls but had
dry blood around the genital area at the end of May 2010,
suggesting that she might have aborted a litter. The other
treated female (RG) that was cycling and had relatively low
antibody titres did not give birth. In summary, in 2010,
4–6 years after treatment with GonaCon, nine out of the
10 treated females were still infertile and at least 5 out of 6
control females gave birth. The difference in reproductive
output between treated and control was signiﬁcant (Fishers’s
Test P = 0.008).

The Agonistic Interaction index varied with treatment (c2 = 48.85,
d.f. = 1, P < 0.001) but not with trial (c2 = 3.56, d.f. = 1, P = 0.06),
vaccination period (c2 = 2.48, d.f. = 34, P = 1), treatment*trial
(c2 = 0.35, d.f. = 1, P = 0.55) and treatment*vaccination period
(c2 = 21.35, d.f. = 34, P = 0.95). For ease of presentation, the AI
indices were converted to social ranks (Fig. 2) derived by
calculating an AI for each animal on each day and by ranking
the AIs from 1 to 12, with 12 indicating the highest social rank. The
results of the analysis indicated that animals in treated groups
had initially higher AI indices than controls but that vaccination
had no effect on aggressiveness as both groups of animals
maintained their ranks throughout the trials.
Bodyweight increased with time in both groups. In Trial 2,
the bodyweight of treated and control females did not differ
(F1,59 < 1.0, P = 0.665) up to 54 months after vaccination (Fig. 3).
There were no differences between GonaCon-treated
and control wild boar in biochemical (Wilk’s statistic =
0.0896, F14,1 = 0.726, P = 0.740) or haematological (Wilk’s
statistic = 0.8722, F9,6 = 0.098, P = 0.999) variables (Table 2).
No signs of lameness were noticed in treated animals in the
years following vaccination and no obvious granulomata or
abscesses were recorded at the injection site when animals
were examined under anaesthesia by a veterinarian during
regular health checks.
Discussion
Our study showed that a single dose of GonaCon induced
infertility for at least 3–6 years in 11 out of 12 female wild boar.
This contraceptive prevented treated animals from cycling but
did not affect their physiology and behaviour, thus conﬁrming
earlier results (Massei et al. 2008). Treatment with GonaCon
did not affect aggressiveness; the difference between trials
was borderline signiﬁcant (P = 0.06) and might have been due
to small sample size. In addition, the temporary bodyweight
increase in treated females observed three months after
vaccination (Massei et al. 2008) did not persist: at the end of
this study, four years after vaccination, the bodyweight of
treated animals in Trial 2 did not differ from that of controls.
The results on progesterone levels indicated that all six control
and two treated females in Trial 2 were cycling although only
one of these treated females gave birth. This was consistent
with other studies; for instance, white-tailed deer treated with a

Table 1. Faecal progesterone concentration (in ng g–1) recorded between November and December 2009 in individual wild boar females in Trial 2
Treated sows were vaccinated in April 2006. Shaded cells indicate animals that were cycling, as demonstrated by very high concentration of faecal progesterone
(highlighted in bold for each sow)

23 November
26 November
30 November
3 December
8 December
10 December
14 December
17 December

GG

PiW

3823
4212
3686
8199
471
1470
5519
5887

11 825
1696
8323
426
2075
1759
1141
2897

Control
PuY
RY
7560
13 526
2535
1139
194
140
2944
6840

284
454
8980
128
101
3069
617

WO

YPu

GB

GPu

PiPi

Treated
PuO

4725
13 335
12 814
205
759
6748
6998
7401

8579
6988
3409
609
249
365
2427
1717

287
130
179
213
155
977
146
234

385
83
200
375
240
143
197
168

146
1761
258
494
70
68
67
81

149
290
171
222
212
784
178
96

PuPu

RG

4700
6223
1737

8683
1211
814

3882
8792
1060
10 031

14 909
716
4549
9569

382
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Trial 1

11

Table 2. Mean haematological and biochemical variables (þs.d.)
recorded in October 2010 for wild boar females (control and treated
with a single dose of the immunocontraceptive GonaCon in 2004
and 2006)

Control 1
Treated 1

10
9

Variable

8
7
6
5

Mar-05

Feb-05

Control 2
Treated 2

Trial 2

11

Feb-05

Jan-05

Dec-04

Dec-04

Nov-04

Oct-04

Nov-04

Oct-04

Sep-04

Sep-04

Sep-04

Aug-04

Jul-04

Aug-04

Social rank ± SE

4

10
9
8
7
6
5

Apr-07

Mar-07

Feb-07

Jan-07

Dec-06

Nov-06

Oct-06

Aug-06

May-06

Jan-06

Dec-05

Nov-05

4

Fig. 2. Mean social rank of treated and control wild boar females in
Trial 1 and Trial 2 before and after vaccination with GonaCon.
Vaccination date is indicated by a dotted line. The social rank was derived
from the Agonistic Interaction index (AI) = (no. of wins + 1)/(no. of
losses + 1): AIs were calculated for each animal on each day and ranked
so that they ranged from 1 to 12, with 12 indicating the highest social rank.

180
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Months from vaccination
Fig. 3. Mean bodyweight (s.d.) of control (n = 6) and GonaCon-treated
(n = 6) wild boar females in Trial 2.

single-shot Porcine Zona Pellucida immunocontraceptive that
showed signs of breeding behaviour and increased
progesterone levels indicating oestrous did not become
pregnant in the following season (Miller et al. 2009).

Albumin (g dL–1)
Alpha-globulins (g dL–1)
Beta-globulins (g dL–1)
Gamma-globulins (g dL–1)
Ionised calcium (mmol L–1)
Urea (mmol L–1)
Creatinine (mmol L–1)
Alkaline phosphatase (IU L–1)
Aspartate aminotransferase (IU L–1)
Gamma-glutamyl transferase (IU L–1)
Sodium (mmol L–1)
Potassium (mmol L–1)
Calcium (mmol L–1)
Bile acids (mmol L–1)
Haemoglobin (g dL–1)
Packed cell volume (%)
Red blood cell count (1012 L–1)
White blood cell count (109 L–1)
Mean corpuscular volume (ﬂ)
Mean corpuscular haemoglobin
concentration (g dL–1)
Mean corpuscular haemoglobin (pg)
Neutrophils (109 L–1)
Lymphocytes (109 L–1)

Control
(n = 6)

Treated
(n = 10)

33.24 ± 2.78
0.90 ± 1.06
1.92 ± 0.79
14.10 ± 2.03
1.20 ± 0.06
4.1 ± 0.90
172.70 ± 70.40
24.33 ± 4.18
51.17 ± 10.94
55.00 ± 9.65
143.33 ± 3.93
4.82 ± 0.52
2.24 ± 0.08
1.12 ± 1.03
12.28 ± 1.51
0.37 ± 0.04
5.37 ± 0.59
4.87 ± 01.05
68.17 ± 1.94
33.45 + 0.26

33.74 ± 2.21
12.13 ± 1.60
13.28 ± 2.28
13.94 ± 2.24
1.19 ± 0.09
4.42 ± 0.81
170.20 ± 22.89
18.70 ± 6.70
48.00 ± 15.30
43.50 ± 7.41
142.10 ± 2.13
4.99 ± 0.77
2.28 ± 0.10
0.87 ± 0.64
12.39 ± 0.88
0.36 ± 0.03
5.36 ± 0.42
4.97 ± 1.77
67.7 ± 2.16
34.09 + 1.68

22.87 ± 0.65
2.82 ± 1.05
1.73 ± 0.49

23.13 ± 1.25
2.60 ± 1.71
2.09 ± 0.87

Similarly, in deer treated with GonaCon the reproductive
behaviour occurred 1–2 years before the animals became
fertile again (Killian et al. 2008b). A possible explanation is
that follicular development and the production of oestrogen are
sufﬁcient to support reproductive behaviour but inadequate to
restore fertility (Killian et al. 2008b).
This study tested simultaneously the effectiveness and
the potential side-effects of a contraceptive on wild boar
over 4–6 years. Most studies carried out on single-dose
immunocontraceptives in wildlife focussed either on
effectiveness (e.g. Miller et al. 2008b; Killian et al. 2008a;
Gray et al. 2010) or on potential side-effects (e.g. Kirkpatrick
and Turner 2007; Curtis et al. 2008; Gionfriddo et al. 2011;
Yoder and Miller 2011). Results from other studies indicate that
the long-term effectiveness of GonaCon, in terms of both
duration of infertility and proportion of animals rendered
infertile, varies in relation to species and possibly health
condition of the animals. For instance, a single injection of
GonaCon administered to females rendered 100% (n = 6) of
bison (Bison bison) and feral pigs (n = 9) infertile for at least
a year (Miller et al. 2004; Killian et al. 2006a), 91% of
California ground squirrels (Spermophilus beecheyi) infertile
in Year 1 (n = 33) and Year 2 (n = 24) after vaccination (Nash
et al. 2004) and 100% (n = 10) of elk (Cervus elaphus) infertile
for 3 years (Killian et al. 2009). Long-term studies showed
that GnRH antibody titres decrease with time and that
reproduction may resume in some animals in the years
following vaccination. Some of these studies suggested that

Long-term wild boar immunocontraception

the effectiveness of Gonacon, measured as the proportion of
individuals rendered infertile, was greater in captivity than in ﬁeld
trials. For instance GonaCon caused infertility in 80% (n = 5) of
captive white-tailed deer (Odocoileus virginianus) for ﬁve years
(Miller et al. 2008b) but a subsequent study carried out with freeliving animals (Gionfriddo et al. 2009) reported infertility in 88%
and 47% of the deer (n = 28) during the ﬁrst and second year after
vaccination. Similarly, in captive wild horses GonaCon caused
infertility in 94%, 60% and 53% of the mares (n = 15) in Year 1, 2
and 3 following vaccination (Killian et al. 2008a) but in freeroaming feral horses GonaCon caused infertility in 39%, 42%
and 31% of the mares (Gray et al. 2010). These differences might
be due to the possibility that the better body conditions, usually
found in captive animals, might affect immunocompetence and
hence the strength and persistence of the immune response to the
vaccine (Gray et al. 2010). Differences in immune response to
vaccines might also be due to species, age, sex, reproductive
status (pregnant versus non-pregnant animals), genetic variation
in populations and exposure to other antigens (e.g. Buehler et al.
2011; Demas et al. 2011). Understanding the role these factors
play in shaping an individual’s response to immunocontraception
will assist to optimise fertility control applications in terms of
candidate species, timing of treatment and context. For instance,
if pregnancy were found to affect immunocompetence, animals
could be treated before the reproductive peak; likewise, animals
might be vaccinated outside seasonal food shortages that might
affect their health and thus their immune response. Field trials
with free-living wild boar should be conducted to determine
whether the results found in this study can be replicated in
ﬁeld conditions.
Several studies found no side-effects of GonaCon on the
physiology and behaviour of animals treated with GonaCon.
For instance, GonaCon did not affect bodyweight or blood
chemistry of black-tailed prairie dogs (Cynomys ludovicianus)
(Yoder and Miller 2011) and blood chemistry in white-tailed
deer (Killian et al. 2006b). However, other studies in whitetailed deer, cats and elk reported that animals treated with
GonaCon developed palpable non-painful injection site
granulomata or sterile abscesses that did not seem to affect
the welfare of the animals (Killian et al. 2006b; Curtis et al.
2008; Gionfriddo et al. 2009; Levy et al. 2011). The granuloma
at the injection site plays a prime role in the host’s defence
against the ‘chronic infection’ represented by a multiyear
immunocontraceptive and is considered necessary to the
efﬁcacy of the adjuvant (Miller et al. 2008a). As all methods
employed in wildlife management to decrease population size
have advantages and disadvantages (e.g. Massei et al. 2011), the
occurrence and potential implications of side-effects must be
viewed against alternative options to contraception such as lethal
control.
The results of this study conﬁrmed that injectable GonaCon
met the safety and effectiveness criteria required for an ideal
fertility control agent. For wildlife applications, an oral
immunocontraceptive would be preferable to an injectable one
as it would eliminate the costs of trapping and handling animals.
However, as GnRH is widely conserved among mammals, it is
likely that an oral formulation could affect non-target species
(Levy 2011). Thus an oral GnRH vaccine would require the use
of a species-speciﬁc delivery system, such as those developed
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to deliver pharmaceuticals to wild pigs (Long et al. 2010; Massei
et al. 2010b).
In the current injectable formulation, immunocontraceptives
can have a variety of ﬁeld applications in situations where culling
is not feasible, desirable or legal. These include control of
overabundant wildlife in urban areas and parks, iconic species
for which culling is publicly unacceptable, and protected areas
where hunting is not allowed. Other applications of these
immunocontraceptives concern instances when population size
reduction is required for disease control, particularly when
alternative options, such as culling, have the potential for
social perturbation. Several authors highlighted that culling
can affect social behaviour and lead to increased disease
transmission whilst fertility control is unlikely to have similar
effects (e.g. Smith and Cheeseman 2002; McDonald et al. 2008;
Killian et al. 2009; Harrison et al. 2010). In addition, fertility
control can induce behavioural changes, such as reproductionrelated long-distance movements, that reduce disease
transmission rates (e.g. Caley and Ramsey 2001; Ramsey
et al. 2002; Ramsey 2007).
GonaCon is currently registered in the US as a contraceptive
for white-tailed deer (Fagerstone et al. 2010). Whilst many
traditional forms of intervention are subject to increasing
public criticism, the longevity, safety and social acceptability
of this immunocontraceptive for managing overabundant
wildlife offer a credible alternative to lethal control. Field trials
are now needed to test the feasibility, effectiveness and costs of
managing free-living populations through fertility control based
on immunocontraception.
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